...
首页> 外文期刊>Archives of gynecology and obstetrics. >Efficacy of low-dose hCG in late follicular phase in controlled ovarian stimulation using GnRH agonist protocol.
【24h】

Efficacy of low-dose hCG in late follicular phase in controlled ovarian stimulation using GnRH agonist protocol.

机译:使用GnRH激动剂方案在控制性卵巢刺激中卵泡后期低剂量hCG的功效。

获取原文
获取原文并翻译 | 示例

摘要

Safe, simple and cost-effective protocol is an important goal in ART cycles. The aim of this prospective study was whether administration of low-dose hCG in late follicular phase can be used clinically to replace gonadotropin administration in GnRH long protocol.122 patients who were candidates for ART enrolled the study and randomly divided into two groups. The control group (n?=?62) received standard long protocol and gonadotropin administration continued until the day of hCG injection (10,000?IU) for final follicular maturation. The study group (n?=?60) received GnRH long protocol and when at least ≥6 follicles with mean diameter ≥12?mm were observed in both ovaries, hMG was displaced by 200?IU per day of hCG until final follicular maturation.There were no significant differences in age, basal FSH, infertility duration and infertility etiology between two groups. There were no statistically significant differences between two groups regarding chemical pregnancy, clinical pregnancy, ongoing pregnancy, and abortion per cycle (50, 40, 40, and 20?% in study group vs. 45.2, 35.5, 35.5, and 21.4?% in control group, respectively). Mean dose of used gonadotropins was significantly higher in control group than that in the study group (2,524?±?893?IU in control group and 1,439?±?433?IU in study group) (p?=?0.000).According to our data, we recommend the use of low-dose hCG in GnRH long protocol because of lower doses of used gonadotropins.
机译:安全,简单和具有成本效益的协议是ART周期的重要目标。这项前瞻性研究的目的在于,在GnRH长期研究方案中,是否可以在卵泡后期应用低剂量hCG代替临床上的促性腺激素。122例接受ART治疗的患者参加了该研究,随机分为两组。对照组(n≥62)接受标准的长期方案,促性腺激素的给药一直持续到注射hCG(10,000?IU)直至卵泡最终成熟为止。研究组(n≥60)接受GnRH长期方案,并且当两个卵巢中均观察到至少≥6个平均直径≥12mm的卵泡时,hMG每天以200μIU的hCG置换直至最终卵泡成熟。两组的年龄,基础FSH,不孕持续时间和不孕病因学无显着差异。两组在化学妊娠,临床妊娠,持续妊娠和每周期流产方面无统计学差异(研究组分别为50%,40%,40%和20%,而对照组为45.2%,35.5%,35.5%和21.4%)。对照组)。对照组中促性腺激素的平均剂量显着高于研究组(对照组为2524±±893?IU,研究组为1439±±433?IU)(p≥0.000)。我们的数据,由于使用的促性腺激素剂量较低,我们建议在GnRH长方案中使用低剂量hCG。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号